Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Reason
Superpotent and Failed Tablet/Capsule Specifications
Classification
Class II
Status
Terminated
Lot
Batch # PF4520028B & PF4520028A, Exp. Date 11/2022
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.